AT
Aspicio Therapeutics, Inc.
SEC filingOther Health Care · Downingtown, PA
Amount raised$200Ksold at filing
Total offering$200K
Investors in the raise2count reported to the SEC
FiledJul 17, 2026first sale Jul 16, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Michael KeaneExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.